Maze Therapeutics, Inc. Common Stock (MAZE) — Cash Flow Quality Index
Maze Therapeutics, Inc. Common Stock (MAZE) has a Cash Flow Quality Index of 1.04x as of June 2024. Operating cash flow of $145.05 Million exceeds net income of $139.06 Million, indicating high earnings quality where cash backs reported profits. Explore Maze Therapeutics, Inc. Common Stock operating cash flow efficiency to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Maze Therapeutics, Inc. Common Stock Cash Flow Quality Index (2024–2024)
Historical Cash Flow Quality Index for Maze Therapeutics, Inc. Common Stock across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Maze Therapeutics, Inc. Common Stock total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Maze Therapeutics, Inc. Common Stock (2024–2024)
Year-by-year earnings quality comparison for Maze Therapeutics, Inc. Common Stock. For live market cap and the full company financial profile, see Maze Therapeutics, Inc. Common Stock market cap and net worth.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.45x | $75.95 Million | $52.23 Million | — |